SITC's Anniversary Awards celebrate the achievements of current and future leaders in the cancer immunotherapy field. The work of these dedicated individuals that include young investigators, luminaries, leading organizations, regulatory agencies and industry seeks to propel the field forward and build a solid foundation for future advances and soon, a cure.
In 2021, SITC was humbled to present the inaugural SITC Medal of Honor to Uğur Şahin, MD and Özlem Türeci, MD for their efforts championing the development and distribution of the vaccine against COVID-19 using mRNA technology. SITC recognizes their incredible contributions to humanity and the countless lives saved.
In 2017, SITC recognized Sean Parker with the SITC Public Service Award, which honors an individual or group that has made substantial contributions to fostering and enhancing the field of cancer immunotherapy through increasing public understanding and awareness, research efforts, and/or funding for cancer immunotherapy.
- Recipient: Sean Parker – Parker Institute for Cancer Immunotherapy
In 2019, SITC recognized Dr. Martin “Mac” Cheever with the Distinguished Service Award for his work establishing and directing the Cancer Immunotherapy Trials Network (CITN). The CITN designs and conducts early-stage, multicenter clinical trials of promising immunotherapy agents. Without the CITN trials and Dr. Cheever’s leadership and vision, patients would not have access to these promising experimental drugs.
- Recipient: Martin “Mac” A. Cheever, MD – Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, University of Washington